Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 203080
Company: MICRO LABS LTD
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
NEVIRAPINE NEVIRAPINE 200MG TABLET;ORAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
05/22/2012 ORIG-1 Approval

Label is not available on this site.

NEVIRAPINE

TABLET;ORAL; 200MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
NEVIRAPINE NEVIRAPINE 200MG TABLET;ORAL Prescription No AB 077521 AUROBINDO
NEVIRAPINE NEVIRAPINE 200MG TABLET;ORAL Prescription No AB 077956 CIPLA
NEVIRAPINE NEVIRAPINE 200MG TABLET;ORAL Prescription No AB 078584 HETERO LABS LTD III
NEVIRAPINE NEVIRAPINE 200MG TABLET;ORAL Prescription No AB 090688 MACLEODS PHARMS LTD
NEVIRAPINE NEVIRAPINE 200MG TABLET;ORAL Prescription No AB 203080 MICRO LABS LTD
NEVIRAPINE NEVIRAPINE 200MG TABLET;ORAL Prescription No AB 078864 MYLAN LABS
NEVIRAPINE NEVIRAPINE 200MG TABLET;ORAL Prescription No AB 202523 MYLAN PHARMS INC
NEVIRAPINE NEVIRAPINE 200MG TABLET;ORAL Prescription No AB 078644 PRINSTON INC
NEVIRAPINE NEVIRAPINE 200MG TABLET;ORAL Prescription No AB 078195 STRIDES PHARMA
VIRAMUNE NEVIRAPINE 200MG TABLET;ORAL Prescription Yes AB 020636 BOEHRINGER INGELHEIM

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English